Opening GPAtlas…

🔭 The Scope · one-page clinical infographic

Polymyalgia Rheumatica (PMR)

Polymyalgia Rheumatica (PMR) on one page: when to suspect it, assessment, management, red flags, referral criteria and GP tips.

Written and reviewed by practising UK GPs, overseen by our Clinical Advisory Officer. Last reviewed 22 Jan 2026.

🔍 When to Suspect

A patient aged 50 or over presents with an acute onset of bilateral shoulder and/or hip girdle aching and significant morning stiffness lasting more than 45 minutes

From the full topic in The Ocean Library: Polymyalgia Rheumatica (PMR)

🧭 When to suspect

Polymyalgia rheumatica (PMR) is the commonest inflammatory rheumatic disease of older adults and one of the largest single indications for long-term oral steroids in primary care. Suspect it in a patient aged 50 or over with relatively rapid-onset (typically less than 2 weeks) bilateral aching and stiffness of the shoulder and/or pelvic (hip) girdle, with prominent morning stiffness lasting more than 45 minutes. Systemic features – fatigue, malaise, low-grade fever, weight loss, low mood – are common.

Two clinical skills matter most: confirm the diagnosis against the “core four” (and exclude mimics) before committing to a long steroid course, and screen persistently for giant cell arteritis (GCA), the sight-threatening large-vessel vasculitis that overlaps with PMR. The British Society for Rheumatology (BSR) frames PMR as a working diagnosis confirmed over time. Because viral myalgia can mimic early PMR, confirm symptoms have persisted for at least 2 weeks before labelling.

Core diagnostic feature Typical finding
Age 50 or over – PMR is rare below 50, so reconsider the diagnosis in younger patients.
Onset & duration Relatively acute, evolving over < 2 weeks; symptoms present for ≥ 2 weeks before diagnosis.
Pain distribution Bilateral aching/stiffness of the shoulder and/or pelvic girdle, often with the neck.
Morning stiffness > 45 minutes, with “gelling” after periods of inactivity.
Inflammatory markers Raised ESR and/or CRP – but normal or borderline in around 1 in 5.
Steroid response A rapid, marked response to low-dose prednisolone supports the diagnosis.

Raise suspicion particularly in those of European family origin and consider the overlap with GCA throughout: up to 1 in 5 PMR patients develop GCA, and a substantial minority have subclinical large-vessel involvement.

Source: BSR · EULAR/ACR 2015

⚠️ Common pitfall

Reaching for steroids before the work-up is complete. In pure PMR (no GCA features) there is no urgency to treat before excluding mimics – premature prednisolone masks alternative diagnoses and confounds the inflammatory markers you will rely on later. Remember too that a response to steroids does not confirm PMR: late-onset rheumatoid arthritis (RA), spondyloarthritis, inflammatory myopathy and occasionally malignancy or infection can all partially respond.


🔒 Sign up free to see the full infographic

You're viewing a free preview. Create a free account to unlock the rest.

Sign up free →
Inside the full infographic 🔒 Assessment🔒 Management🔒 Red Flags🔒 Referral Criteria🔒 GP Tips 🔒 The one-page image

Sample infographics are open to everyone in the Free Sample Bundle.

Read the full Polymyalgia Rheumatica (PMR) topic → · Part of The Scope, 160+ one-page infographic summaries, each distilled from its Ocean Library topic.

We use cookies to enhance your browsing experience, provide personalised content, and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Privacy policy